Sarah Day - Global Healthcare Marketing Therapy
GBCS Stock | USD 1.70 0.00 0.00% |
Insider
Sarah Day is Marketing Therapy of Global Healthcare REIT
Phone | 303-449-2100 |
Web | https://www.gbcsreit.com |
Global Healthcare Management Efficiency
Global Healthcare's management efficiency ratios could be used to measure how well Global Healthcare manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
Showing other executives | INSIDER Age | ||
Tamla OatesForney | Summit Materials | 48 | |
Chris Gaskill | Summit Materials | N/A | |
Miteshkumar Thakkar | Consol Energy | 45 | |
Nathan Tucker | Consol Energy | N/A | |
Christopher Gaskill | Summit Materials | 42 | |
Christopher Durborow | Griffon | N/A | |
Ken Sloan | Olympic Steel | N/A | |
Tamla Forney | Summit Materials | 49 | |
Timothy Harris | Allegheny Technologies Incorpor | 49 | |
John Mooney | Olympic Steel | N/A | |
Lisa Christen | Olympic Steel | 47 | |
Thomas Gibbons | Griffon | N/A | |
Tom Wright | Allegheny Technologies Incorpor | N/A | |
James Sight | Griffon | 65 | |
Jerome Coben | Griffon | 76 | |
Cheryl Turnbull | Griffon | 60 |
Management Performance
Return On Equity | -0.6 | |||
Return On Asset | -2.0E-4 |
Global Healthcare REIT Leadership Team
Elected by the shareholders, the Global Healthcare's board of directors comprises two types of representatives: Global Healthcare inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Global. The board's role is to monitor Global Healthcare's management team and ensure that shareholders' interests are well served. Global Healthcare's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Global Healthcare's outside directors are responsible for providing unbiased perspectives on the board's policies.
Lance Baller, Interim CEO, Interim Pres and Director | ||
Sarah Day, Marketing Therapy | ||
Christine Lucus, CFO Sec | ||
Christopher Barker, COO Pres |
Global Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Global Healthcare a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | -0.6 | |||
Return On Asset | -2.0E-4 | |||
Profit Margin | (0.05) % | |||
Operating Margin | (0.0004) % | |||
Current Valuation | 50.96 M | |||
Shares Outstanding | 3.07 M | |||
Shares Owned By Insiders | 24.97 % | |||
Price To Earning | 46.73 X | |||
Price To Book | 3.95 X | |||
Price To Sales | 0.39 X |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Global Pink Sheet Analysis
When running Global Healthcare's price analysis, check to measure Global Healthcare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Global Healthcare is operating at the current time. Most of Global Healthcare's value examination focuses on studying past and present price action to predict the probability of Global Healthcare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Global Healthcare's price. Additionally, you may evaluate how the addition of Global Healthcare to your portfolios can decrease your overall portfolio volatility.